Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 2,112.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 0
  • Market Cap: £4,957.28m
  • RiskGrade: 125
  • Beta: 0.01

Hikma surges as investors welcome medium-term guidance

By Michele Maatouk

Date: Thursday 15 May 2025

LONDON (ShareCast) - (Sharecast News) - Shares in Hikma Pharmaceuticals surged on Thursday as investors welcomed new medium-term guidance from the company.
Alongside a sell-side analysts and investors even at its manufacturing and R&D facility in Columbus, Ohio, the pharmaceuticals group said that for group revenue, it expects a three-year compound annual growth rate of 6% to 8% between 2024 and 2027.

For operating profit, it expects a three-year compound annual growth rate of 7% to 9%.

In addition, Hikma said introduced a five-year target for group revenue to reach $5bn by 2030.

At 1235 BST, the shares were up 8.1% at 2,098p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 2,112.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 0
Shares Issued 234.72m
Market Cap £4,957.28m
Beta 0.01
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.22% below the market average91.22% below the market average91.22% below the market average91.22% below the market average91.22% below the market average
48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average48.94% below the sector average
Price Trend
59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average
70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average
Income
3.41% below the market average3.41% below the market average3.41% below the market average3.41% below the market average3.41% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
30.99% above the market average30.99% above the market average30.99% above the market average30.99% above the market average30.99% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page